Physician profile
Steven Bennett
NPI 1871173559
$4,655.03
in general payments reported to CMS, 2019-2025
12 companies · $2,218 in 2025
The $2,218 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $513 · 2023: $807 · 2024: $1,118 · 2025: $2,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,464 · Travel and Lodging: $572 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,464.47 |
| Travel and Lodging | $572.45 |
| Education | $105.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,780.84 | 2022-2025 | Mako, Gamma, Triathlon |
| Smith+Nephew, INC. | $706.36 | 2022-2025 | Healicoil, Bone Anchors With Arthroscopic Delivery System, Evos |
| Acumed LLC | $699.88 | 2025 | Acumed |
| Zimmer Biomet Holdings, INC. | $629.12 | 2024-2025 | Avenir, Arcos, G7 |
| Legacy Ortho LLC | $305.62 | 2024-2025 | |
| Heron Therapeutics, INC. | $124.22 | 2024 | Zynrelef |
| Cdc Medical LLC | $113.35 | 2023 | |
| Cerapedics INC. | $105.60 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Kci USA, INC. | $84.92 | 2022 | |
| Sanara Medtech INC. | $62.65 | 2025 | Celleraterx |
| Dendreon Pharmaceuticals LLC | $23.69 | 2025 | Provenge |
| Endo Pharmaceuticals INC. | $18.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.